News

7th India-Japan Medical Product Regulatory Symposium Held in New Delhi

New Delhi: The Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare, Government of India, successfully hosted the 7th India-Japan Medical Product Regulatory Symposium at the FICCI Convention Hall. This event, part of the ongoing collaboration between India and Japan, is in line with the Memorandum of Cooperation (MoC) signed to foster joint efforts in medical product regulations.

Approximately 200 delegates attended the symposium, including representatives from the Ministry of Health & Family Welfare, India, and the Ministry of Health, Labour and Welfare (MHLW), Japan. Regulatory authorities from CDSCO, India, and the Pharmaceuticals and Medical Devices Agency (PMDA), Japan, along with industry leaders from the pharmaceutical, medical devices, and biologicals-biosimilar sectors, participated in the event.

The MoC, signed in December 2015, underscores mutual cooperation in medical product regulations and is set to continue until December 2025. These symposiums are alternately hosted in India and Japan, serving as essential platforms for exchanging insights and enhancing regulatory practices.

The symposium featured insightful presentations by Indian and Japanese drug regulatory authorities, followed by in-depth discussions on emerging topics in pharma, medical devices, and regenerative medicines. These deliberations were pivotal in updating industry stakeholders on the latest regulatory initiatives in both countries.

The inaugural session was graced by esteemed dignitaries including Rajiv Wadhawan, Joint Secretary, MoHFW; Dr. Rajeev Singh Raghuvanshi, DCGI, CDSCO; Yada Shinji, Executive Director, PMDA; Dr. Hirota Mitsue, Deputy Director, MHLW; and Dr. Ranga Chandrashekar, JDCI, CDSCO. The event garnered participation from 80 drug regulators and 120 industry representatives from India and Japan, facilitating fruitful exchanges on regulatory updates and best practices.

The symposium underscored the commitment of both nations to enhance cooperation in the field of medical product regulations, aiming to ensure the safety, efficacy, and quality of medical products available in both countries. This collaborative effort is expected to pave the way for more streamlined regulatory processes and foster innovation in the medical products sector.

Bureau The News Hashtag

Recent Posts

Odisha Opens Five Hirakud Gates, Begins Controlled Water Release from Reservoirs Ahead of Possible Cyclone

Bhubaneswar: The Odisha Government has initiated advance reservoir management measures across the State ahead of…

12 hours ago

Odisha Steps Up Urban Relief and Restoration After Cyclone Arnab; Extra Engineers Deployed in Brahmapur

Bhubaneswar: The Odisha Housing and Urban Development Department has intensified relief and restoration operations in…

12 hours ago

Telecom Services Restored in 99% of Ganjam Blocks After Cyclone Arnab

Bhubaneswar: Telecom connectivity has been restored in 99 per cent of blocks in Ganjam district…

12 hours ago

Severe Cyclonic Storm Murasu to Hit South Andhra Coast Between Monday Night and Tuesday Morning

Bhubaneswar: With Cyclonic Storm ‘Murasu’ gaining strength over the Bay of Bengal, the IMD has…

12 hours ago

Rabi Narayan Naik Reviews Cyclone Arnab Restoration, Stresses Drinking Water Supply and Road Connectivity

Bhubaneswar: Rural Development, Panchayati Raj and Drinking Water Minister Rabi Narayan Naik has directed officials…

13 hours ago

Water Resources Principal Secretary Reviews Drainage Systems in Ganjam After Cyclone Arnab

Bhubaneswar: Principal Secretary of the Water Resources Department Shubha Sarma continued her field-level assessment of…

13 hours ago